WRAP News

In the podcast Expert Voices in Dementia, WRAP principal investigator Sterling Johnson, PhD, shares news about detecting Alzheimer’s disease through blood testing and the important implications this research could have on Alzheimer’s disease treatment. Johnson’s lab is investigating the protein p-tau217 as a blood-based biomarker for early detection of Alzheimer’s disease.

The selected paper, which utilizes Wisconsin ADRC and WRAP participant data, maps a timeline of amyloid and tau accumulation in the brain

On March 6, Sterling Johnson, PhD, participated in a news conference for the media to discuss the importance of federally funded Alzheimer’s disease research at UW–Madison and its impact on people throughout Wisconsin and nationwide.

To stay informed about federal funding changes that impact UW Alzheimer’s disease research programs, please visit the UW–Madison Office of Federal Relations updates page.

Research participants have begun volunteering for brain scans at the University of Wisconsin School of Medicine and Public Health in Madison for a national study on Alzheimer’s disease and related dementias. 

The researchers examined pathological data from 3,297 brain donors and biomarkers and clinical data from over 10,000 people, including participants from WRAP and five large multicenter cohorts in Europe and the US.

Researchers examined data from participants enrolled in three studies, including the Wisconsin Registry for Alzheimer’s Prevention (WRAP)

The news report interviews a participant enrolled in African Americans Fighting Alzheimer’s in Midlife and describes the health disparities in Alzheimer’s disease.

The grant is the largest NIH funding in university history